STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about OXSQ
Insiders, 180 days
+$326.0K net bought
2 buyers · 1 seller · 0% of sales under a 10b5-1 plan
Oxford Square Capital insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Oxford Square Capital Corp. insiders bought a net $326.0K of stock across 79 Form 4 purchases and sales, with 2 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.
38 earlier Form 4 trades (code P or S) here by this insider (38 buys), the last on May 27, 2022.
-0.8% median (-1.1% mean) 90-day return after 30 previous buys.
The trade is 6.6% of the 2,201,479 shares held after it.
1 other insider bought within 30 days.
Insider activity: President and COO ROSENTHAL SAUL B bought about $166.4K of OXSQ on May 20, 2026, the largest insider purchase at the company on our record; 1 other insider bought within 30 days.
38 earlier Form 4 trades (code P or S) here by this insider (38 buys), the last on May 27, 2022.
-0.8% median (-1.1% mean) 90-day return after 30 previous buys.
The trade is 6.0% of the 2,417,193 shares held after it.
1 other insider bought within 30 days.
Insider activity: Chief Executive Officer COHEN JONATHAN H bought about $166.4K of OXSQ on May 20, 2026, the largest insider purchase at the company on our record; 1 other insider bought within 30 days.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM OXSQ
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM OXSQ
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM OXSQ
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
0.95x
long-term 2023-12-31 (30 months older than the period end) plus current 2023-12-31 (30 months older than the period end); equity 2026-06-30
Debt to equity OXSQ
FY Dec 2025
0.89x
FY Dec 2024
0.80x
FY Dec 2023
0.85x
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
0.95x
Mar 2026
1.05x
Dec 2025
0.89x
Sep 2025
0.81x
Jun 2025
0.82x
Mar 2025
0.87x
Dec 2024
0.80x
Sep 2024
0.81x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.36x
TTM operating cash flow over long-term 2023-12-31 (30 months older than the period end) plus current 2023-12-31 (30 months older than the period end)
Cash flow to debt OXSQ
FY Dec 2025
-0.11x
FY Dec 2024
0.20x
FY Dec 2023
0.51x
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
-0.36x
Mar 2026
-0.26x
Dec 2025
-0.11x
Sep 2025
-0.17x
Jun 2025
0.03x
Mar 2025
0.09x
Dec 2024
0.20x
Sep 2024
0.32x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-25.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity OXSQ
FY Dec 2025
-12.2%
FY Dec 2024
+3.8%
FY Dec 2023
+11.9%
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
-25.0%
Mar 2026
-26.6%
Dec 2025
-12.2%
Sep 2025
-1.6%
Jun 2025
-0.9%
Mar 2025
-0.3%
Dec 2024
+3.8%
Sep 2024
-2.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-12.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets OXSQ
FY Dec 2025
-6.2%
FY Dec 2024
+2.0%
FY Dec 2023
+5.7%
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
-12.9%
Mar 2026
-12.8%
Dec 2025
-6.2%
Sep 2025
-0.8%
Jun 2025
-0.5%
Mar 2025
-0.2%
Dec 2024
+2.0%
Sep 2024
-1.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital OXSQ
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed OXSQ
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
4.92x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing OXSQ
FY Dec 2025
5.68x
FY Dec 2024
5.67x
FY Dec 2023
5.61x
FY Dec 2022
7.26x
FY Dec 2021
n/a
Jun 2026
5.50x
Mar 2026
6.56x
Dec 2025
5.68x
Sep 2025
4.82x
Jun 2025
6.19x
Mar 2025
6.37x
Dec 2024
5.67x
Sep 2024
5.90x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$221.4M
market value at close 2026-10-26 on 2026-08-07 shares, plus long-term 2023-12-31 (30 months older than the period end) plus current 2023-12-31 (30 months older than the period end), minus cash 2026-06-30
Enterprise value OXSQ
FY Dec 2025
$220.7M
FY Dec 2024
$259.7M
FY Dec 2023
$289.4M
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
$217.8M
Mar 2026
$242.9M
Dec 2025
$220.7M
Sep 2025
$202.2M
Jun 2025
$258.3M
Mar 2025
$273.8M
Dec 2024
$259.7M
Sep 2024
$266.2M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield OXSQ
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -33%, PEG needs growth
PEG, trailing OXSQ
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
0.30x
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
OXSQ ranks highest on insider conviction (72nd percentile) and risk and compliance (18th), and lowest on profitability (1st), among Funds & Trusts peers.
Profitability
1
Inputs
Return on equity-25.0% · 3 pct, sector of 37
Return on assets-12.9% · 0 pct, sector of 38
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
15
Inputs
Debt to equity0.95x · 27 pct, universe of 3,589
Cash flow to debt-0.36x · 3 pct, sector of 30
Insider conviction
72
Inputs
Net Form 4 buying (codes P and S), 180d$326K · 74 pct, sector of 144
Insider buyers, 180d2 · 70 pct, sector of 144
Risk and compliance
18
Inputs
Short interest, % of shares outstanding (no float on file)+4.5% · 18 pct, sector of 46
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Growth, Institutional and government, US patents
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
OXSQ filings, in plain words
Are Oxford Square Capital insiders buying or selling OXSQ?
In the 180 days to 2026-10-28, Oxford Square Capital insiders were net buyers, a net $326.0K: $332.8K of purchases and $6.8K of sales reported on Form 4, by 2 buyers and 1 seller.
Read the full summary
In the 180 days to 2026-10-28, Oxford Square Capital insiders were net buyers of OXSQ, a net $326.0K across purchases and sales reported on Form 4 by 2 buyers and 1 seller. Purchases outweighed sales more than tenfold by value. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.